New Mexico 2019 Regular Session Status: Enacted 1 D cosponsors

SB 221 — REQUIRE CERTAIN OVERDOSE COUNSELINGS

Last action — Signed

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 10, 2019. Enacted.

Prognosis

Likely to advance 72% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 D).

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

112 added · 243 removed

Plain-language change summary

The recent amendments to Bill SB 221 require health care providers to inform patients about the risks associated with opioid overdose and the availability of overdose reversal medication, specifically an opioid antagonist like naloxone. This change aims to encourage better communication between doctors and patients about the dangers of opioid use, ultimately helping to reduce the risk of overdose deaths. By making this advisory and co-prescribing practice mandatory under certain conditions, the bill seeks to empower patients with knowledge and tools for safer opioid usage.

→
Previous
Latest
SENATE BILL 221 TH LEGISLATURE - STATEOFNEWMEXICO- FIRST SESSION, 2019 INTRODUCED BY William P.
Soules Pursuant to House Rule 24-1, this document incorporates amendments that have been adopted prior to consideration of this measure by the House.
It is a tool to show the amendments in context and is not to be used for the purpose of amendments.
REQUIRING HEALTH CARE PROVIDERS, h UNDER CERTAIN CIRCUMSTANCES, TO SJCºCOUNSEL»SJC g o SJCºADVISE»SJC PATIENTS ON THE RISKS OF OVERDOSE AND OPIOID t hr g e i k OVERDOSE REVERSAL MEDICATION AND TO HHHCºOFFER»HHHC h r i s HHHCºCO-PRESCRIBE AN»HHHC SJCºNALOXONE»SJC SJCºOPIOID h , t, ANTAGONIST»SJC HHHCºPRESCRIPTIONS»HHHC.
REQUIRING HEALTH CARE PROVIDERS, UNDER CERTAIN CIRCUMSTANCES, TO ADVISE PATIENTS ON THE RISKS OF OVERDOSE AND OPIOID OVERDOSE REVERSAL MEDICATION AND TO CO-PRESCRIBE AN OPIOID ANTAGONIST.
e u g e b l e e h n d d i = = o h BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
7 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
l ] b ,d i a º e HHHCºSECTION 1.
SECTION 1.
Section 24-2D-1 NMSA 1978 (being Laws r i = r t e w d m a n o 1999, Chapter 126, Section 1) is amended to read:
Section 24-2D-1 NMSA 1978 (being Laws 1999, Chapter 126, Section 1) is amended to read:
d m :
"24-2D-1.
b e d s º o t n = .211704.1 s k m e e a n e d r e l u [ A d "24-2D-1.
SHORT TITLE.--Chapter 24, Article 2D NMSA 1978 may be cited as the "Pain Relief Act"." SECTION 2.
SHORT TITLE.--[This act] Chapter 24, Article 2D NMSA 1978 may be cited as the "Pain Relief Act"."»HHHC SECTION HHHCº1.
Section 24-2D-2 NMSA 1978 (being Laws 1999, Chapter 126, Section 2, as amended) is amended to read:
2.»HHHC Section 24-2D-2 NMSA 1978 (being Laws 1999, Chapter 126, Section 2, as amended) is amended to read:
"board" means the licensing board of a health care provider;
"board" means the licensing board of a health SB 221 Page 1 care provider;
h D.
D.
"chronic pain" means pain that persists after u » r t h reasonable medical efforts have been made to relieve the pain g e l i or its cause and that continues, either continuously or h r i s episodically, for longer than three consecutive months.
"chronic pain" means pain that persists after reasonable medical efforts have been made to relieve the pain or its cause and that continues, either continuously or episodically, for longer than three consecutive months.
h , e h t u g "Chronic pain" does not include pain associated with a terminal e b l e e , gh condition or with a progressive disease that, in the normal n d d i = = o h course of progression, may reasonably be expected to result in l ] b ,d i a º r e r = a terminal condition;
"Chronic pain" does not include pain associated with a terminal condition or with a progressive disease that, in the normal course of progression, may reasonably be expected to result in a terminal condition;
t e w d m a n o E.
E.
"clinical expert" means a person who by reason d m :
"clinical expert" means a person who by reason of specialized education or substantial relevant experience in pain management has knowledge regarding current standards, practices and guidelines;
b r e t º o t n = .211704.1 s k m e e a n e d r e l u [ A d of specialized education or substantial relevant experience in pain management has knowledge regarding current standards, practices and guidelines;
"opioid analgesic" means buprenorphine, butorphanol, codeine, hydrocodone, hydromorphine, levorphanol, meperidine, methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and propoxyphene as well as their h brand names, isomers and combinations;
"opioid analgesic" means buprenorphine, butorphanol, codeine, hydrocodone, hydromorphine, levorphanol, meperidine, methadone, morphine, nalbuphine, SB 221 Page 2 oxycodone, oxymorphone, pentazocine and propoxyphene as well as their brand names, isomers and combinations;
u » r I.
I.
"opioid antagonist" means a drug approved by the t h g e l i federal food and drug administration that when administered h r i s negates or neutralizes in whole or in part the pharmacological h , e h effects of an opioid analgesic in the body, including naloxone t u g e b l e e , gh and such other medications approved by the board of pharmacy n d d i = = o h for the reversal of opioid analgesic overdoses;
"opioid antagonist" means a drug approved by the federal food and drug administration that when administered negates or neutralizes in whole or in part the pharmacological effects of an opioid analgesic in the body, including naloxone and such other medications approved by the board of pharmacy for the reversal of opioid analgesic overdoses;
l ] b ,d i a º r [H.] J.
J.
and e r = t e w d m a n o [I.] K.
and K.
"therapeutic purpose" means the use of d m :
"therapeutic purpose" means the use of pharmaceutical and non-pharmaceutical medical treatment that conforms substantially to accepted guidelines for pain management." SECTION 3.
b r e t º o t n = .211704.1 s k m e - 3 - e a n e d r e l u [ A d pharmaceutical and non-pharmaceutical medical treatment that conforms substantially to accepted guidelines for pain management." SECTION HHHCº 2.
A new section of the Pain Relief Act is enacted to read:
3.»HHHC A new section of the Pain Relief Act is enacted to read:
"REQUIREMENTS FOR HEALTH CARE PROVIDERS WHO PRESCRIBE, DISTRIBUTE OR DISPENSE OPIOID ANALGESICS.-- A.
"[NEW MATERIAL] REQUIREMENTS FOR HEALTH CARE PROVIDERS WHO PRESCRIBE, DISTRIBUTE OR DISPENSE OPIOID ANALGESICS.-- HHHCº SflºA.»Sfl»HHHC HHHCºA.»HHHC A health care provider who prescribes, distributes or dispenses an opioid analgesic for the first time to a patient shall SJCº counsel»SJC SJCºadvise»SJC the patient on the risks of overdose and inform the patient of the availability of an opioid antagonist.
A health care provider who prescribes, distributes or dispenses an opioid analgesic for the first time to a patient shall advise the patient on the risks of overdose and inform the patient of the availability of an opioid antagonist.
With respect to a patient to whom an opioid analgesic has previously been prescribed, distributed or dispensed by the health care provider, the health care provider shall SJCº counsel»SJC SJCºadvise»SJC the patient on the risks h of overdose and inform the patient of the availability of an u » r opioid antagonist on the first occasion that the health care t h g e l i provider prescribes, distributes or dispenses an opioid h r i s analgesic each calendar year.
With respect to a patient to whom an opioid analgesic has previously been prescribed, distributed or dispensed by the health care provider, the health care SB 221 Page 3 provider shall advise the patient on the risks of overdose and inform the patient of the availability of an opioid antagonist on the first occasion that the health care provider prescribes, distributes or dispenses an opioid analgesic each calendar year.
HHHCº Sflº”»Sfl»HHHC h , e h HHHCºSflºB.
B.
A health care provider who prescribes t u g e b l e e , gh an opioid analgesic for a patient shall offer the patient a n d d i = = o h prescription for SJCºnaloxone»SJC SJCºan opioid l ] b ,d i a º r antagonist»SJC, within the scope of the health care provider's e r = t e w d m a n o authorized practice, unless otherwise indicated in the d m :
A health care provider who prescribes an opioid analgesic for a patient shall co-prescribe an opioid antagonist if the amount of opioid analgesic being prescribed is at least a five-day supply.
b r e t º o t n = .211704.1 s k m e - 4 - e a n e d r e l u [ A d professional judgment of the health care provider.
The prescription for the opioid antagonist shall be accompanied by written information regarding the temporary effects of the opioid antagonist and techniques for administering the opioid antagonist.
A prescription for SJCºnaloxone»SJC SJCºan opioid antagonist»SJC shall be accompanied by written information regarding the temporary effects of SJCºnaloxone»SJC SJCºthat opioid antagonist»SJC, techniques for administration of SJCºnaloxone»SJC SJCºthat opioid antagonist»SJC and a warning that a person administering SJCºnaloxone»SJC SJCºan opioid antagonist»SJC should call 911 immediately after administering SJCºnaloxone»SJC SJCºan opioid antagonist»SJC.”»Sfl»HHHC HHHCºB.
That written information shall contain a warning that a person administering the opioid antagonist should call 911 immediately after administering the opioid antagonist." SB 221 Page 4 25
A health care provider who prescribes an opioid analgesic for a patient shall»HHHC HHHCºoffer the patient a prescription for naloxone, within the scope of the health care provider's authorized practice, unless otherwise indicated in the professional judgment of the health care provider.
A prescription for naloxone shall be accompanied by written information regarding the temporary effects of naloxone, h techniques for administration of naloxone and a warning that a u » r t h person administering naloxone should call 911 immediately after g e l i administering naloxone."»HHHC HHHCºco-prescribe an opioid h r i s antagonist if the amount of opioid analgesic being prescribed h , e h t u g is at least a five-day supply.
The prescription for the opioid e b l e e , gh antagonist shall be accompanied by written information n d d i = = o h l ] b ,d regarding the temporary effects of the opioid antagonist and i a º r e r = techniques for administering the opioid antagonist.
That t e w d m a n o d m :
b r e t º o t n = .211704.1 s k m e - 5 - e a n e d r e l u [ A d written information shall contain a warning that a person administering the opioid antagonist should call 911 immediately after administering the opioid antagonist."»HHHC - 6 - » g o » r h t i k l i g t h s , e h t l i w l b l e e , g n d l h = = b , a l º d i a r e r = , a t e d m a n o d m :
b r e t º o t n = .211704.1 s k em e e a n e d r e l u [ A d
View plain text versions (3)

Action History

  1. Signed

  2. Senate concurred in House amendments

  3. passed House

  4. DO PASS, as amended, committee report adopted

  5. DO PASS committee report adopted

  6. Sent to House Consumer & Public Affairs Committee & House Health & Human Services Committee

  7. passed Senate

  8. floor substitute adopted (2 amendment)

  9. DO PASS, as amended, committee report adopted

  10. DO PASS committee report adopted

  11. Sent to Senate Public Affairs Committee & Senate Judiciary Committee

  12. Sent to Senate Pre-file

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 111 not signed on · 3 voted No

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (111)

111 members have not signed on to this bill.

Show all 111 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

senate passage

Passed 34 Yea · 8 Nay
Party YeaNayPresentNot Voting
Republican 3300
Unaffiliated 19500
Democrat 12000
Total 34800
% of votes cast 81%19%0%0%
How each member voted (42)
Member Party Vote
PAPEN — Yea
PAYNE — Yea
BURT — Yea
RODRIGUEZ — Yea
CISNEROS — Yea
RUE — Yea
FULFER — Yea
SANCHEZ — Yea
SAPIEN — Yea
SEDILLO-LOPEZ — Yea
INGLE — Yea
IVEY-SOTO — Yea
KERNAN — Yea
SMITH — Yea
NEVILLE — Yea
TALLMAN — Yea
O'NEILL — Yea
WHITE — Yea
PIRTLE — Nay
CANDELARIA — Nay
GOULD — Nay
GRIGGS — Nay
MOORES — Nay
ORTIZ y PINO — Yea
Antoinette Sedillo Lopez Democrat Yea
Benny Shendo, Jr. Democrat Yea
Elizabeth "Liz" Stefanics Democrat Yea
George K. Muñoz Democrat Yea
Jeff Steinborn Democrat Yea
Joseph Cervantes Democrat Yea
Michael Padilla Democrat Yea
Mimi Stewart Democrat Yea
Pete Campos Democrat Yea
Peter Wirth Democrat Yea
Shannon D. Pinto Democrat Yea
William P. Soules Democrat Yea
Alan T. Martinez Republican Yea
Brian G. Baca Republican Yea
Craig W. Brandt Republican Nay
Gabriel Ramos Republican Yea
Pat Woods Republican Nay
William E. Sharer Republican Nay

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 221?
SB 221 is sponsored by William P. Soules (Democrat).
What is the current status of SB 221?
This bill has been enacted into law. Introduced January 10, 2019. Enacted.
Where can I track SB 221?
Track SB 221 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 221

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 221

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →